Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Diastika Biotekindo Tbk (CHEK) Fair Value & Analysis

Healthcare · ID · Market cap 461B IDR

Price128.00 IDR
Fair Value77.75 IDR
Upside-39.3%
Quality87/100
Evidence: Medium Range 55.80 IDR – 99.70 IDR

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

PT Diastika Biotekindo Tbk (CHEK) currently trades at 128.00 IDR, while our model-based Fair Value estimate is 77.75 IDR — implying the stock looks roughly 39.3% overvalued today. We read business quality at 87/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

PT Diastika Biotekindo Tbk engages in the sale of disposable or consumable medical goods and diagnostic equipment in Indonesia. It operates through Clinical Diagnostic Group and Life Science Group segments. The company offers various products for detecting, diagnosing, and monitoring human disease. It also provides life science products that are processed from biological products. In addition, the company engages in general trading, laboratory equipment, research, medicine, export and import, pharmaceutical chemicals, services, electronics, and industrial activities. PT Diastika Biotekindo was founded in 1989 and is headquartered in Jakarta Timur, Indonesia. PT Diastika Biotekindo Tbk is a subsidiary of PT Optel Investama Mulia.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is PT Diastika Biotekindo Tbk (CHEK) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 77.75 IDR versus a price of 128.00 IDR — about −39% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CHEK?
Our 21-model fair value for PT Diastika Biotekindo Tbk is 77.75 IDR (as of Jun 24, 2026), built from audited fundamentals. The current price is 128.00 IDR.
What is the quality score of CHEK?
PT Diastika Biotekindo Tbk has a Quality Score of 87/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.